Conformational and enantiotropic polymorphism of a 1: 1 cocrystal involving ethenzamide and ethylmalonic acid

被引:58
作者
Aitipamula, Srinivasulu [1 ]
Chow, Pui Shan [1 ]
Tan, Reginald B. H. [1 ,2 ]
机构
[1] ASTAR, Inst Chem & Engn Sci, Singapore 627833, Singapore
[2] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore
来源
CRYSTENGCOMM | 2010年 / 12卷 / 11期
关键词
PHARMACEUTICAL CO-CRYSTALS; MOLECULAR-CRYSTALS; HYDROGEN-BONDS; SUPRAMOLECULAR SYNTHONS; THERMODYNAMIC RULES; CARBOXYLIC-ACIDS; CARBAMAZEPINE; PHASES; SOLVENT; COMPLEXES;
D O I
10.1039/c004491a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Polymorphism in cocrystals is increasingly gaining interest because of the overwhelming interest in pharmaceutical cocrystals. In this paper, we report a 1 : 1 cocrystal of an analgesic drug, ethenzamide (EA), with ethylmalonic acid (EMA) which exists in two polymorphic forms. Both the polymorphs were characterized by various analytical techniques, such as single-crystal and powder X-ray diffraction, differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), hot-stage microscopy (HSM) and variable temperature X-ray diffraction (VTXRD). Crystal structure analysis suggests that the EMA molecules in both the polymorphs adopt different conformations but feature a common hydrogen bonding motif. Thermal analysis suggests that the polymorphs are related enantiotropically. Based on the information obtained from the thermal data and various other experiments, a semi-schematic energy-temperature diagram was constructed. Interestingly, it was observed that the polymorphic outcome of solid-state grinding is remarkably dependent on the polarity of the solvent used in the solvent-drop grinding experiments.
引用
收藏
页码:3691 / 3697
页数:7
相关论文
共 51 条
[21]   SUPRAMOLECULAR SYNTHONS IN CRYSTAL ENGINEERING - A NEW ORGANIC-SYNTHESIS [J].
DESIRAJU, GR .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1995, 34 (21) :2311-2327
[22]   HYDROGEN-BONDS AS DESIGN ELEMENTS IN ORGANIC-CHEMISTRY [J].
ETTER, MC .
JOURNAL OF PHYSICAL CHEMISTRY, 1991, 95 (12) :4601-4610
[23]   Crystal engineering of the composition of pharmaceutical phases:: Multiple-component crystalline solids involving carbamazepine [J].
Fleischman, SG ;
Kuduva, SS ;
McMahon, JA ;
Moulton, B ;
Walsh, RDB ;
Rodríguez-Hornedo, N ;
Zaworotko, MJ .
CRYSTAL GROWTH & DESIGN, 2003, 3 (06) :909-919
[24]   Recent Advances in Understanding the Mechanism of Cocrystal Formation via Grinding [J].
Friscic, Tomislav ;
Jones, William .
CRYSTAL GROWTH & DESIGN, 2009, 9 (03) :1621-1637
[25]  
Hirasawa N, 1999, CHEM PHARM BULL, V47, P417, DOI 10.1248/cpb.47.417
[26]   The 2:1 cocrystal of benzamide and pentafluorobenzoic acid [J].
Jankowski, Wojciech ;
Gdaniec, Maria ;
Polonski, Tadeusz .
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2006, 62 (08) :O492-O494
[27]   STUDIES ON COMBINATION DOSING .3. ASPIRIN AND ETHENZAMIDE [J].
KAWANO, O ;
SAWABE, T ;
MISAKI, N ;
FUKAWA, K .
JAPANESE JOURNAL OF PHARMACOLOGY, 1978, 28 (06) :829-835
[28]  
LIN S, 2007, J PHARM SCI, V2, P211
[29]   Crystal engineering of the composition of pharmaceutical phases. 3. Primary amide supramolecular heterosynthons and their role in the design of pharmaceutical co-crystals [J].
McMahon, JA ;
Bis, JA ;
Vishweshwar, P ;
Shattock, TR ;
McLaughlin, OL ;
Zaworotko, MJ .
ZEITSCHRIFT FUR KRISTALLOGRAPHIE, 2005, 220 (04) :340-350
[30]   Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation [J].
Nehm, SJ ;
Rodríguez-Spong, B ;
Rodríguez-Hornedo, N .
CRYSTAL GROWTH & DESIGN, 2006, 6 (02) :592-600